» Articles » PMID: 31471050

Management of Giant Pituitary Adenomas: Role and Outcome of the Endoscopic Endonasal Surgical Approach

Overview
Specialty Neurosurgery
Date 2019 Sep 1
PMID 31471050
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Giant adenomas represent a significant surgical challenge. Although traditionally several transcranial and transsphenoidal microscopic approaches have had a central role in their management, in the last 2 decades here have been increasing reports of the endoscopic endonasal approach for giant adenomas, citing its improved resection rates and lower complication profile. However, its role as the preferred approach has not been fully established and there is currently a paucity of evidence-based recommendations available in the literature. This article reviews the current literature and attempts to define the role and outcomes of the endoscopic endonasal surgical approach for giant pituitary adenomas.

Citing Articles

Giant and irregular pituitary neuroendocrine tumors surgery: comparison of simultaneous combined endoscopic endonasal and transcranial and purely endoscopic endonasal surgery at a single center.

Fu J, Luo W, Zhang C, Wang Z, Fan W, Lin Y Chin Neurosurg J. 2025; 11(1):3.

PMID: 39894800 PMC: 11789305. DOI: 10.1186/s41016-025-00389-4.


Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis.

Oberman D, Sanchez-Garavito E, Perez-Vega C, Donaldson A, Olomu O, Graepel S Pituitary. 2025; 28(1):19.

PMID: 39863739 DOI: 10.1007/s11102-024-01476-y.


The impact of non-clinical factors in pituitary surgery.

Almeida J Pituitary. 2025; 28(1):17.

PMID: 39757271 DOI: 10.1007/s11102-024-01491-z.


Collaborative Human-Computer Vision Operative Video Analysis Algorithm for Analyzing Surgical Fluency and Surgical Interruptions in Endonasal Endoscopic Pituitary Surgery: Cohort Study.

Wong C, Chen P, Hsu H, Cheng S, Fan C, Chen Y J Med Internet Res. 2024; 26:e56127.

PMID: 38963694 PMC: 11258519. DOI: 10.2196/56127.


Management Approaches and Patient Outcomes for Giant Pituitary Neuroendocrine Tumors Classified as Knosp Grade 3 and 4.

Nakase K, Nishimura F, Yokoyama S, Kakutani M, Kim T, Matsuda R Cureus. 2024; 16(4):e57498.

PMID: 38707178 PMC: 11066726. DOI: 10.7759/cureus.57498.